Efficacy of Targeted ECO/miR-200c Nanoparticles for Modulating Tumor Microenvironment and Treating Triple Negative Breast Cancer as Non-invasively Monitored by MR Molecular Imaging

Overexpression of Extradomain-B Fibronectin is Associated with Invasion of Breast Cancer Cells

(2020) Amita Vaidya et al.   Cells

The role and mechanisms of action of microRNAs in cancer drug resistance

(2019) Wengong Si et al.   Clinical Epigenetics

Systemic Delivery of Tumor-Targeting siRNA Nanoparticles against an Oncogenic LncRNA Facilitates Effective Triple-Negative Breast Cancer Therapy

(2019) Amita M Vaidya et al.   BIOCONJUGATE CHEMISTRY

Formulation of Biocompatible Targeted ECO/siRNA Nanoparticles with Long-Term Stability for Clinical Translation of RNAi

(2019) Nadia R. Ayat et al.   Nucleic Acid Therapeutics

Fibronectin in Cancer: Friend or Foe

(2019) Tsung-Cheng Lin et al.   Cells

Effective MR Molecular Imaging of Triple Negative Breast Cancer With an EDB-Fibronectin-Specific Contrast Agent at Reduced Doses

(2019) Nadia R. Ayat et al.   Frontiers in Oncology

MicroRNAs in regulation of triple-negative breast cancer progression

(2018) Dominika Piasecka et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Magnetic resonance molecular imaging of metastatic breast cancer by targeting extradomain-B fibronectin in the tumor microenvironment

(2017) Zheng Han et al.   MAGNETIC RESONANCE IN MEDICINE

Targeted gadofullerene for sensitive magnetic resonance imaging and risk-stratification of breast cancer

(2017) Zheng Han et al.   Nature Communications

Overexpression of suppressive microRNAs, miR-30a and miR-200c are associated with improved survival of breast cancer patients

(2017) Tsutomu Kawaguchi et al.   Scientific Reports

Targeted Multifunctional Lipid ECO Plasmid DNA Nanoparticles as Efficient Non-viral Gene Therapy for Leber’s Congenital Amaurosis

(2017) Da Sun et al.   Molecular Therapy-Nucleic Acids

Fibronectin-targeted drug delivery in cancer

(2016) Heena Kumra et al.   ADVANCED DRUG DELIVERY REVIEWS

miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance

(2016) Merve Mutlu et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

EMT in Breast Carcinoma—A Review

(2016) Joema Felipe Lima et al.   Journal of Clinical Medicine

EDB Fibronectin Specific Peptide for Prostate Cancer Targeting

(2015) Zheng Han et al.   BIOCONJUGATE CHEMISTRY

Silencing β3 Integrin by Targeted ECO/siRNA Nanoparticles Inhibits EMT and Metastasis of Triple-Negative Breast Cancer

(2015) Jenny G. Parvani et al.   CANCER RESEARCH

Decreased expression of MicroRNA-200 family in human breast cancer is associated with lymph node metastasis

(2015) Feng Xu et al.   Clinical & Translational Oncology

Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential

(2015) J Knezevic et al.   ONCOGENE

Tissue stiffness regulates serine/arginine-rich protein-mediated splicing of the extra domain B-fibronectin isoform in tumors

(2015) Francois Bordeleau et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Design and evaluation of new pH-sensitive amphiphilic cationic lipids for siRNA delivery

(2013) Anthony S. Malamas et al.   JOURNAL OF CONTROLLED RELEASE

Microenvironmental Regulation of Epithelial-Mesenchymal Transitions in Cancer

(2012) D. Gao et al.   CANCER RESEARCH

miR-200c Sensitizes Breast Cancer Cells to Doxorubicin Treatment by Decreasing TrkB and Bmi1 Expression

(2012) Florian Kopp et al.   PLoS One

Emerging Role of MicroRNAs in Drug-Resistant Breast Cancer

(2011) SARMILA MAJUMDER et al.   GENE EXPRESSION

MicroRNA-200c Represses Migration and Invasion of Breast Cancer Cells by Targeting Actin-Regulatory Proteins FHOD1 and PPM1F

(2011) S. Jurmeister et al.   MOLECULAR AND CELLULAR BIOLOGY

Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells

(2009) Y. Li et al.   CANCER RESEARCH

Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells

(2009) Yohei Shimono et al.   CELL

MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents

(2009) D. R. Cochrane et al.   MOLECULAR CANCER THERAPEUTICS

Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers

(2009) Dawn R. Cochrane et al.   Journal of Oncology

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

(2008) Philip A. Gregory et al.   NATURE CELL BIOLOGY